BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 523806)

  • 1. The effect of route of infection on acquired resistance to Fasciola hepatica in the rat and sheep.
    Kelly JD; Campbell NJ
    Res Vet Sci; 1979 Sep; 27(2):205-9. PubMed ID: 523806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
    Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
    Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response in cattle, sheep and rats to infection with gamma-irradiated metacercariae of Fasciola hepatica.
    Hughes DL; Hanna RE; Doy TG
    Res Vet Sci; 1982 May; 32(3):354-8. PubMed ID: 7100653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Taenia hydatigena infection on existing and concurrent infections of Fasciola hepatica in sheep.
    Campbell NJ; Dineen JK; Kelly JD
    Res Vet Sci; 1979 May; 26(3):391-3. PubMed ID: 515530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful passive transfer of resistance to Fasciola hepatica infection in rats by immune serum and transfer factor.
    Mitchell GB; Armour J; Ross JG; Halliday WG
    Res Vet Sci; 1981 Mar; 30(2):246-7. PubMed ID: 7255916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-resistance between Schistosoma mansoni and Fasciola hepatica in sheep.
    Haroun EM; Hillyer GV
    J Parasitol; 1988 Oct; 74(5):790-5. PubMed ID: 3138395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flukicidal action of closantel against immature and mature Fasciola hepatica in experimentally infected rats and sheep.
    Maes L; Lauwers H; Deckers W; Vanparijs O
    Res Vet Sci; 1988 Mar; 44(2):229-32. PubMed ID: 3387677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of resistance to Fasciola hepatica infection in sheep by a regime involving the use of the immunomodulatory compound L tetramisole (levamisole).
    Mitchell GB; Armour J
    Res Vet Sci; 1981 May; 30(3):343-8. PubMed ID: 7255928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of Fasciola hepatica infected sheep to various infection levels.
    Chauvin A; Moreau E; Boulard C
    Vet Res; 2001; 32(1):87-92. PubMed ID: 11254181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocastor coypus as a reservoir host of Fasciola hepatica in France.
    Ménard A; Agoulon A; L'Hostis ML; Rondelaud D; Collard S; Chauvin A
    Vet Res; 2001; 32(5):499-508. PubMed ID: 11592619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
    Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
    Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of sheep to challenge infection with Fasciola hepatica.
    Sandeman RM; Howell MJ
    Res Vet Sci; 1981 May; 30(3):294-7. PubMed ID: 6114523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The resistance of sheep to Fasciola hepatica: studies on the pathophysiology of challenge infections.
    Sinclair KB
    Res Vet Sci; 1975 Nov; 19(3):296-303. PubMed ID: 1061964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
    Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
    Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The different stages of Fasciola hepatica capable of inducing immunity and the susceptibility of various stages to immunological attack in the sensitised rat.
    Hughes DL; Harness E; Doy TG
    Res Vet Sci; 1981 Jan; 30(1):93-8. PubMed ID: 7244387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the main route of drug entry in adult Fasciola hepatica: Further insights into closantel pharmacological activity.
    Ceballos L; Canton C; Cadenazzi G; Larsen K; Virkel G; Moreno L; Fairweather I; Lanusse C; Alvarez L
    Exp Parasitol; 2017 Oct; 181():23-29. PubMed ID: 28734749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasciola hepatica: characterization of somatic and excretory-secretory antigens of adult flukes recognized by infected sheep.
    Ruiz-Navarrete MA; Arriaga C; Bautista CR; Morilla A
    Rev Latinoam Microbiol; 1993; 35(3):301-7. PubMed ID: 8047733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to demonstrate resistance in goats, sheep and cattle to Fasciola hepatica after infection with Cysticercus tenuicollis.
    Hughes DL; Harness E; Doy TG
    Res Vet Sci; 1978 Nov; 25(3):356-9. PubMed ID: 749087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of Fasciola hepatica in rats and rabbits following sensitising infection and treatment.
    Haroun EM; Hammond JA; Sewell MM
    Res Vet Sci; 1980 May; 28(3):377-9. PubMed ID: 7414093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species.
    Phiri IK; Phiri AM; Harrison LJ
    Vet Parasitol; 2006 Nov; 141(3-4):234-42. PubMed ID: 16797844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.